Clovis: 2Q Earnings Snapshot

August 1, 2018

BOULDER, Colo. (AP) _ Clovis Oncology Inc. (CLVS) on Wednesday reported a loss of $101.2 million in its second quarter.

On a per-share basis, the Boulder, Colorado-based company said it had a loss of $1.94.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.38 per share.

The biopharmaceutical company posted revenue of $23.8 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $23.4 million.

Clovis shares have dropped 32 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $46.01, a decline of 44 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CLVS at https://www.zacks.com/ap/CLVS

Update hourly